{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:24:42Z","timestamp":1780093482027,"version":"3.54.0"},"reference-count":140,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T00:00:00Z","timestamp":1428969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007155","name":"MRC","doi-asserted-by":"publisher","award":["MR\/K015419\/1"],"award-info":[{"award-number":["MR\/K015419\/1"]}],"id":[{"id":"10.13039\/501100007155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Influenza A virus is a respiratory pathogen which causes both seasonal epidemics and occasional pandemics; infection continues to be a significant cause of mortality worldwide. Current influenza vaccines principally stimulate humoral immune responses that are largely directed towards the variant surface antigens of influenza. Vaccination can result in an effective, albeit strain-specific antibody response and there is a need for vaccines that can provide superior, long-lasting immunity to influenza. Vaccination approaches targeting conserved viral antigens have the potential to provide broadly cross-reactive, heterosubtypic immunity to diverse influenza viruses. However, the field lacks consensus on the correlates of protection for cellular immunity in reducing severe influenza infection, transmission or disease outcome. Furthermore, unlike serological methods such as the standardized haemagglutination inhibition assay, there remains a large degree of variation in both the types of assays and method of reporting cellular outputs. T-cell directed immunity has long been known to play a role in ameliorating the severity and\/or duration of influenza infection, but the precise phenotype, magnitude and longevity of the requisite protective response is unclear. In order to progress the development of universal influenza vaccines, it is critical to standardize assays across sites to facilitate direct comparisons between clinical trials.<\/jats:p>","DOI":"10.3390\/vaccines3020293","type":"journal-article","created":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T10:32:00Z","timestamp":1429007520000},"page":"293-319","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and Challenges"],"prefix":"10.3390","volume":"3","author":[{"given":"Lynda","family":"Coughlan","sequence":"first","affiliation":[{"name":"The Jenner Institute, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX1 7DQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Lambe","sequence":"additional","affiliation":[{"name":"The Jenner Institute, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX1 7DQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,4,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMra1002842","article-title":"Influenza vaccines for the future","volume":"363","author":"Lambert","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","article-title":"The annual impact of seasonal influenza in the US: Measuring disease burden and costs","volume":"25","author":"Molinari","year":"2007","journal-title":"Vaccine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","article-title":"Influenza virus hemagglutinin stalk-based antibodies and vaccines","volume":"3","author":"Krammer","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1128\/JVI.03509-12","article-title":"H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice","volume":"87","author":"Margine","year":"2013","journal-title":"J. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.chom.2010.05.009","article-title":"Influenza virus evolution, host adaptation, and pandemic formation","volume":"7","author":"Taubenberger","year":"2010","journal-title":"Cell Host Microbe"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1093\/molbev\/msl102","article-title":"Avian influenza virus exhibits rapid evolutionary dynamics","volume":"23","author":"Chen","year":"2006","journal-title":"Mol. Biol. Evol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM198307073090103","article-title":"Cytotoxic T-cell immunity to influenza","volume":"309","author":"McMichael","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1086\/652441","article-title":"Recipients of vaccine against the 1976 \u201cswine flu\u201d have enhanced neutralization responses to the 2009 novel H1N1 influenza virus","volume":"50","author":"McCullers","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","volume":"3","author":"Throsby","year":"2008","journal-title":"PLOS ONE"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Coughlan, L., Mullarkey, C., and Gilbert, S. (2015). Adenoviral vectors as novel vaccines for influenza. J. Pharm. Pharmacol.","DOI":"10.1111\/jphp.12350"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1242\/jcs.114.5.845","article-title":"At the crossroads of cell biology and immunology: DRiPs and other sources of peptide ligands for MHC class I molecules","volume":"114","author":"Yewdell","year":"2001","journal-title":"J. Cell Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.16.1.323","article-title":"Mechanisms of MHC class I\u2014restricted antigen processing","volume":"16","author":"Pamer","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/jnci\/djt184","article-title":"MHC class I antigen processing and presenting machinery: Organization, function, and defects in tumor cells","volume":"105","author":"Leone","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.iy.11.040193.002155","article-title":"The biochemistry and cell biology of antigen processing and presentation","volume":"11","author":"Germain","year":"1993","journal-title":"Annu. Rev. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e1002381","DOI":"10.1371\/journal.ppat.1002381","article-title":"Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates","volume":"7","author":"Weinfurter","year":"2011","journal-title":"PLOS Pathog."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.micinf.2011.01.007","article-title":"Immunity to seasonal and pandemic influenza A viruses","volume":"13","author":"Valkenburg","year":"2011","journal-title":"Microbes. Infect."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4614-6217-0_12","article-title":"Decisions on the road to memory","volume":"785","author":"Amsen","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virusres.2011.09.022","article-title":"Immune responses to influenza virus infection","volume":"162","author":"Kreijtz","year":"2011","journal-title":"Virus Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9178","DOI":"10.1073\/pnas.1105624108","article-title":"Systematic identification of immunodominant CD8+ T-cell responses to influenza A virus in HLA-A2 individuals","volume":"108","author":"Wu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e1000085","DOI":"10.1371\/journal.ppat.1000085","article-title":"Cellular proteins in influenza virus particles","volume":"4","author":"Shaw","year":"2008","journal-title":"PLOS Pathog."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.4049\/jimmunol.159.11.5197","article-title":"CD8+ T cells clear influenza virus by perforin or Fas-dependent processes","volume":"159","author":"Topham","year":"1997","journal-title":"J. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1084\/jem.20101850","article-title":"Antiviral CD8+ T cell effector activities in situ are regulated by target cell type","volume":"208","author":"Hufford","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.vaccine.2014.11.054","article-title":"Virus-specific T cells as correlate of (cross-)protective immunity against influenza","volume":"33","author":"Altenburg","year":"2015","journal-title":"Vaccine"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1084\/jem.189.2.423","article-title":"Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection","volume":"189","author":"Cerwenka","year":"1999","journal-title":"J. Exp. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.4049\/jimmunol.0801814","article-title":"Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge","volume":"182","author":"Hamada","year":"2009","journal-title":"J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"12388","DOI":"10.1128\/JVI.76.23.12388-12393.2002","article-title":"Compromised influenza virus-specific CD8+-T-cell memory in CD4+-T-cell-deficient mice","volume":"76","author":"Belz","year":"2002","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.1083317","article-title":"Defective CD8 T cell memory following acute infection without CD4 T cell help","volume":"300","author":"Sun","year":"2003","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e40733","DOI":"10.1371\/journal.pone.0040733","article-title":"Pulmonary infection with influenza A virus induces site-specific germinal center and T follicular helper cell responses","volume":"7","author":"Boyden","year":"2012","journal-title":"PLOS ONE"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.coviro.2013.05.002","article-title":"Clearance of influenza virus infections by T cells: Risk of collateral damage?","volume":"3","author":"Hillaire","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ni.3031","article-title":"Molecular regulation of effector and memory T cell differentiation","volume":"15","author":"Chang","year":"2014","journal-title":"Nat. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/imr.12087","article-title":"Tissue-resident memory T cells","volume":"255","author":"Shin","year":"2013","journal-title":"Immunol. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.4049\/jimmunol.152.4.1653","article-title":"Heterosubtypic immunity to influenza type-A virus in mice\u2014Effector mechanisms and their longevity","volume":"152","author":"Liang","year":"1994","journal-title":"J. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e16245","DOI":"10.1371\/journal.pone.0016245","article-title":"Resident memory T cells (T(RM)) are abundant in human lung: Diversity, function, and antigen specificity","volume":"6","author":"Purwar","year":"2011","journal-title":"PLOS ONE"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.coviro.2013.05.001","article-title":"Role of T cell immunity in recovery from influenza virus infection","volume":"3","author":"Sun","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1086\/656188","article-title":"Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model","volume":"202","author":"Laurie","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/498980","article-title":"Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: An experiment of nature","volume":"193","author":"Epstein","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1099\/vir.0.048652-0","article-title":"Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses","volume":"94","author":"Hillaire","year":"2013","journal-title":"J. Gen. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1128\/JVI.02694-07","article-title":"Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus","volume":"82","author":"Kreijtz","year":"2008","journal-title":"J. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1128\/JVI.00519-10","article-title":"Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus","volume":"84","author":"Tu","year":"2010","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"20365","DOI":"10.1073\/pnas.0911580106","article-title":"Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population","volume":"106","author":"Greenbaum","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1128\/JVI.02226-09","article-title":"Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus","volume":"84","author":"Ge","year":"2010","journal-title":"J. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.4049\/jimmunol.176.10.6333","article-title":"T cell responses are better correlates of vaccine protection in the elderly","volume":"176","author":"McElhaney","year":"2006","journal-title":"J. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1128\/CVI.00397-07","article-title":"Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children","volume":"15","author":"Forrest","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1086\/648406","article-title":"Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial","volume":"200","author":"Beran","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Jefferson, T.O., Rivetti, D., di Pietrantonj, C., Rivetti, A., and Demicheli, V. (2007). Vaccines for preventing influenza in healthy adults. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD004879.pub3"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<94::AID-JMV15>3.0.CO;2-C","article-title":"Mismatch between the 1997\/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly","volume":"61","author":"Beyer","year":"2000","journal-title":"J. Med. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Jefferson, T., Rivetti, A., Harnden, A., di Pietrantonj, C., and Demicheli, V. (2008). Vaccines for preventing influenza in healthy children. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD004879.pub3"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa1215817","article-title":"Vaccine for prevention of mild and moderate-to-severe influenza in children","volume":"369","author":"Jain","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e1190","DOI":"10.1371\/journal.pone.0001190","article-title":"Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets","volume":"2","author":"Heiny","year":"2007","journal-title":"PLOS ONE"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1099\/0022-1317-47-2-449","article-title":"Quantification of influenza virus messenger RNAs","volume":"47","author":"Tekamp","year":"1980","journal-title":"J. Gen. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2119\/molmed.2012.00147","article-title":"Novel viral vectored vaccines for the prevention of influenza","volume":"18","author":"Lambe","year":"2012","journal-title":"Mol. Med."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Barnes, E., Folgori, A., Capone, S., Swadling, L., Aston, S., Kurioka, A., Meyer, J., Huddart, R., Smith, K., and Townsend, R. (2012). Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man. Sci. Transl. Med.","DOI":"10.1126\/scitranslmed.3003155"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e41936","DOI":"10.1371\/journal.pone.0041936","article-title":"A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults","volume":"7","author":"Keefer","year":"2012","journal-title":"PLOS ONE"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Ewer, K.J., O\u2019Hara, G.A., Duncan, C.J., Collins, K.A., Sheehy, S.H., Reyes-Sandoval, A., Goodman, A.L., Edwards, N.J., Elias, S.C., and Halstead, F.D. (2013). Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation. Nat. Commun.","DOI":"10.1038\/ncomms3836"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/mt.2012.223","article-title":"ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: Assessment of efficacy against mosquito bite challenge in humans","volume":"20","author":"Sheehy","year":"2012","journal-title":"Mol. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/mt.2013.162","article-title":"Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses","volume":"22","author":"Antrobus","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/mt.2013.284","article-title":"Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza A antigens","volume":"22","author":"Antrobus","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e48322","DOI":"10.1371\/journal.pone.0048322","article-title":"A T cell-inducing influenza vaccine for the elderly: Safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years","volume":"7","author":"Antrobus","year":"2012","journal-title":"PLOS ONE"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/cid\/cis327","article-title":"Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans","volume":"55","author":"Lillie","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciq015","article-title":"Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1","volume":"52","author":"Berthoud","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e62778","DOI":"10.1371\/journal.pone.0062778","article-title":"Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine","volume":"8","author":"Powell","year":"2013","journal-title":"PLOS ONE"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1016\/j.vaccine.2008.06.012","article-title":"FDA\/NIH\/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10\u201311, 2007","volume":"26","author":"Eichelberger","year":"2008","journal-title":"Vaccine"},{"key":"ref_66","unstructured":"Grohskopf, L.A., Shay, D.K., Shimabukuro, T.T., Sokolow, L.Z., Keitel, W.A., Bresee, J.S., and Bresee, N.J. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2013\u20132014. Available online: http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr6207a1.htm."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/S0264-410X(03)00029-X","article-title":"Cost benefit of influenza vaccination in healthy, working adults: An economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine","volume":"21","author":"Nichol","year":"2003","journal-title":"Vaccine"},{"key":"ref_68","first-page":"101","article-title":"Whole-blood assays for cytokine production","volume":"36","author":"Remick","year":"2000","journal-title":"Methods Mol. Med."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Calarota, S.A., and Baldanti, F. (2013). Enumeration and characterization of human memory T cells by enzyme-linked immunospot assays. Clin. Dev. Immunol.","DOI":"10.1155\/2013\/637649"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: Implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/gerona\/63.8.879","article-title":"ELISA and multiplex technologies for cytokine measurement in inflammation and aging research","volume":"63","author":"Leng","year":"2008","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0022-1759(83)90308-3","article-title":"A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells","volume":"65","author":"Czerkinsky","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/15476910903317546","article-title":"ELISPOT assays provide reproducible esults among different laboratories for T-cell immune monitoring\u2014Even in hands of ELISPOT-inexperienced investigators","volume":"6","author":"Zhang","year":"2009","journal-title":"J. Immunotoxicol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jim.2003.09.001","article-title":"Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells","volume":"283","author":"Karlsson","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-1759(01)00535-X","article-title":"A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays","volume":"260","author":"Currier","year":"2002","journal-title":"J. Immunol. Methods"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/CDLI.8.5.871-879.2001","article-title":"Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus","volume":"8","author":"Smith","year":"2001","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/978-1-59259-903-5_18","article-title":"Simultaneous detection of multiple cytokines in ELISPOT assays","volume":"302","author":"Palzer","year":"2005","journal-title":"Methods Mol. Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jim.2003.08.013","article-title":"A Fluorospot assay to detect single T lymphocytes simultaneously producing multiple cytokines","volume":"283","author":"Gazagne","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2567.2009.03073.x","article-title":"The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal priming","volume":"128","author":"Todryk","year":"2009","journal-title":"Immunology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e2027","DOI":"10.1371\/journal.pone.0002027","article-title":"Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans","volume":"3","author":"Todryk","year":"2008","journal-title":"PLOS ONE"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.4049\/jimmunol.175.9.5675","article-title":"Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria","volume":"175","author":"Keating","year":"2005","journal-title":"J. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1086\/507427","article-title":"Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis","volume":"194","author":"Goletti","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.4049\/jimmunol.180.9.5907","article-title":"HIV-1-specific T cell precursors with high proliferative capacity correlate with low viremia and high CD4 counts in untreated individuals","volume":"180","author":"Calarota","year":"2008","journal-title":"J. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nri777","article-title":"Tracking T cells with tetramers: new tales from new tools","volume":"2","author":"Klenerman","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2567.2007.02801.x","article-title":"Class II major histocompatibility complex tetramer staining: Progress, problems, and prospects","volume":"123","author":"Vollers","year":"2008","journal-title":"Immunology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0960-9822(98)70161-7","article-title":"Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood","volume":"8","author":"Dunbar","year":"1998","journal-title":"Curr. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/326881a0","article-title":"Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2","volume":"326","author":"Gotch","year":"1987","journal-title":"Nature"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Maecker, H.T., Hassler, J., Payne, J.K., Summers, A., Comatas, K., Ghanayem, M., Morse, M.A., Clay, T.M., Lyerly, H.K., and Bhatia, S. (2008). Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides. BMC Immunol.","DOI":"10.1186\/1471-2172-9-9"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e8754","DOI":"10.1371\/journal.pone.0008754","article-title":"Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines","volume":"5","author":"Tan","year":"2010","journal-title":"PLOS ONE"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4161\/hv.7.4.13845","article-title":"Highly conserved influenza A sequences as T cell epitopes-based vaccine targets to address the viral variability","volume":"7","author":"Tan","year":"2011","journal-title":"Hum. Vaccin."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.4161\/hv.25598","article-title":"Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011","volume":"9","author":"Moise","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.4049\/jimmunol.1102398","article-title":"MHC class II tetramers","volume":"188","author":"Nepom","year":"2012","journal-title":"J. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-1759(98)00004-0","article-title":"Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry","volume":"212","author":"Suni","year":"1998","journal-title":"J. Immunol. Methods"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/(SICI)1097-0320(20000501)40:1<60::AID-CYTO8>3.0.CO;2-J","article-title":"Optimization of whole blood antigen-specific cytokine assays for CD4+ T cells","volume":"40","author":"Nomura","year":"2000","journal-title":"Cytometry"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00005-014-0293-y","article-title":"Heterogeneity in the differentiation and function of CD8+ T cells","volume":"62","author":"Mittrucker","year":"2014","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (*)","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.immuni.2009.05.001","article-title":"Plasticity of CD4+ T cell lineage differentiation","volume":"30","author":"Zhou","year":"2009","journal-title":"Immunity"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1471-4906(02)02319-0","article-title":"Is selection for TCR affinity a factor in cytokine polarization?","volume":"23","author":"Boyton","year":"2002","journal-title":"Trends Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: An overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/eji.200838336","article-title":"Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication","volume":"38","author":"Ciuffreda","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"12071","DOI":"10.1128\/JVI.01261-07","article-title":"Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines","volume":"81","author":"Kannanganat","year":"2007","journal-title":"J. Virol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.20062363","article-title":"Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses","volume":"204","author":"Precopio","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1002\/eji.200737504","article-title":"Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations","volume":"37","author":"Beveridge","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Qiu, Z., Zhang, M., Zhu, Y., Zheng, F., Lu, P., Liu, H., Graner, M.W., Zhou, B., and Chen, X. (2012). Multifunctional CD4 T cell responses in patients with active tuberculosis. Sci Rep.","DOI":"10.1038\/srep00216"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jim.2011.11.011","article-title":"Optimization of a whole blood intracellular cytokine assay for measuring innate cell responses to mycobacteria","volume":"376","author":"Shey","year":"2012","journal-title":"J. Immunol. Methods"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jim.2004.06.010","article-title":"Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies","volume":"291","author":"Hanekom","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/cdli.2.2.209-213.1995","article-title":"Cytokine production in a whole-blood assay after Epstein-Barr virus infection in vivo","volume":"2","author":"Hornef","year":"1995","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jviromet.2007.04.004","article-title":"Development of a whole blood intracellular cytokine staining assay for mapping CD4+ and CD8+ T-cell responses across the HIV-1 genome","volume":"144","author":"Shalekoff","year":"2007","journal-title":"J. Virol. Methods"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/CVI.00342-09","article-title":"Evaluation of a whole-blood cytokine release assay for use in measuring endotoxin activity of group B Neisseria meningitidis vaccines made from lipid A acylation mutants","volume":"17","author":"Stoddard","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.4049\/jimmunol.161.10.5284","article-title":"Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis","volume":"161","author":"Waldrop","year":"1998","journal-title":"J. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1073\/pnas.0712168105","article-title":"A chemical method for fast and sensitive detection of DNA synthesis in vivo","volume":"105","author":"Salic","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2144\/000112812","article-title":"Detection of S-phase cell cycle progression using 5-ethynyl-2'-deoxyuridine incorporation with click chemistry, an alternative to using 5-bromo-2'-deoxyuridine antibodies","volume":"44","author":"Buck","year":"2008","journal-title":"Biotechniques"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Bradford, J.A., and Clarke, S.T. (2011). Dual-pulse labeling using 5-ethynyl-2'-deoxyuridine (EdU) and 5-bromo-2'-deoxyuridine (BrdU) in flow cytometry. Curr. Protoc. Cytom.","DOI":"10.1002\/0471142956.cy0738s55"},{"key":"ref_115","first-page":"181","article-title":"Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs","volume":"14","author":"Brunner","year":"1968","journal-title":"Immunology"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1586\/erv.10.49","article-title":"New flow cytometric assays for monitoring cell-mediated cytotoxicity","volume":"9","author":"Zaritskaya","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0022-1759(96)00112-3","article-title":"Improved protocol for colorimetric detection of complement-mediated cytotoxicity based on the measurement of cytoplasmic lactate dehydrogenase activity","volume":"196","author":"Sepp","year":"1996","journal-title":"J. Immunol. Methods"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0022-1759(81)90061-2","article-title":"Measurement of lymphocyte cytotoxicity by assessing endogenous alkaline phosphatase activity of the target cells","volume":"40","author":"Szekeres","year":"1981","journal-title":"J. Immunol. Methods"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0022-1759(99)00039-3","article-title":"A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology","volume":"226","author":"Roden","year":"1999","journal-title":"J. Immunol. Methods"},{"key":"ref_120","first-page":"1058","article-title":"FATT-CTL assay for detection of antigen-specific cell-mediated cytotoxicity","volume":"73","author":"Gruters","year":"2008","journal-title":"Cytometry A"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-1759(98)00038-6","article-title":"A novel method for measuring CTL and NK cell-mediated cytotoxicity using annexin V and two-color flow cytometry","volume":"224","author":"Goldberg","year":"1999","journal-title":"J. Immunol. Methods"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1023\/A:1026123223387","article-title":"Measurement of CTL-induced cytotoxicity: The caspase 3 assay","volume":"8","author":"Jerome","year":"2003","journal-title":"Apoptosis"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-1759(01)00359-3","article-title":"A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity","volume":"253","author":"Lecoeur","year":"2001","journal-title":"J. Immunol. Methods"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"e27057","DOI":"10.1371\/journal.pone.0027057","article-title":"Stepwise maturation of lytic granules during differentiation and activation of human CD8+ T lymphocytes","volume":"6","author":"Valitutti","year":"2011","journal-title":"PLOS ONE"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1084\/jem.173.5.1099","article-title":"Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes","volume":"173","author":"Peters","year":"1991","journal-title":"J. Exp. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1359-6446(01)01808-6","article-title":"Virogenomics: A novel approach to antiviral drug discovery","volume":"6","author":"Fruh","year":"2001","journal-title":"Drug Discov. Today"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/infdis\/jiq156","article-title":"Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans","volume":"203","author":"Bucasas","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e52198","DOI":"10.1371\/journal.pone.0052198","article-title":"A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2","volume":"8","author":"Woods","year":"2013","journal-title":"PLOS ONE"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00109-014-1212-8","article-title":"Transcriptomic profiling facilitates classification of response to influenza challenge","volume":"93","author":"Davenport","year":"2015","journal-title":"J. Mol. Med. (Berl.)"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e1002234","DOI":"10.1371\/journal.pgen.1002234","article-title":"Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza a infection","volume":"7","author":"Huang","year":"2011","journal-title":"PLOS Genet."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrg3198","article-title":"MicroRNA profiling: Approaches and considerations","volume":"13","author":"Pritchard","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Liu, Z.P., Wu, H., Zhu, J., and Miao, H. (2014). Systematic identification of transcriptional and post-transcriptional regulations in human respiratory epithelial cells during influenza A virus infection. BMC Bioinform.","DOI":"10.1186\/1471-2105-15-336"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1128\/JVI.06892-11","article-title":"Temporal- and strain-specific host microRNA molecular signatures associated with swine-origin H1N1 and avian-origin H7N7 influenza A virus infection","volume":"86","author":"Loveday","year":"2012","journal-title":"J. Virol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1177\/1753425912473668","article-title":"Expression of innate immune genes, proteins and microRNAs in lung tissue of pigs infected experimentally with influenza virus (H1N2)","volume":"19","author":"Skovgaard","year":"2013","journal-title":"Innate Immun."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e76811","DOI":"10.1371\/journal.pone.0076811","article-title":"microRNAs in circulation are altered in response to influenza A virus infection in humans","volume":"8","author":"Tambyah","year":"2013","journal-title":"PLOS ONE"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(14)70845-X","article-title":"Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: A phase 1, double-blind, randomised controlled trial","volume":"14","author":"Satti","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jim.2014.05.013","article-title":"The Center for HIV\/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells","volume":"409","author":"Needham","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jim.2014.03.024","article-title":"Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal","volume":"409","author":"Ducar","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jim.2014.04.005","article-title":"Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials","volume":"409","author":"Sambor","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/CVI.00326-08","article-title":"Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents","volume":"16","author":"Boaz","year":"2009","journal-title":"Clin. Vaccine Immunol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/3\/2\/293\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:44:41Z","timestamp":1760215481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/3\/2\/293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,14]]},"references-count":140,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,6]]}},"alternative-id":["vaccines3020293"],"URL":"https:\/\/doi.org\/10.3390\/vaccines3020293","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,14]]}}}